LipoTrue
PrivateLast Round
Growth Equity
Oct 1, 2019
Company Overview
LipoTrue operates in Healthcare & Life Sciences and is based in Gavà. Its latest recorded funding round was a Growth Equity round in October 2019.
LipoTrue is a biotechnology company that develops and manufactures advanced active ingredients for the global cosmetic industry.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Fashion & Beauty
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LipoTrue Comparables
Compare LipoTrue with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CODIF Technologie Naturelle | 84% | |
| Vytrus Biotech S.A. | 84% | |
| Provital, S.A. | 82% |
For institutional investors. Book with your work email.
LipoTrue Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
LipoTrue Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Queka Real Partners | Growth Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 19, 2026
Grew 26% QoQ, from 35 to 44 employees.
- Jul 1, 2025
Monthly visitors increased 171% MoM, reaching 13K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventNov 2, 2026
LipoTrue, SL attends in-cosmetics Asia 2026 on Nov 2nd '26 and expands its portfolio with Glintarine(TM), Red Aternaliss(TM), and Kalizyme(TM), available at booth V50.
- launchesNov 1, 2026
At in-cosmetics Asia 2026, LipoTrue, SL introduces Red Aternaliss as one of three new biotechnological cosmetic actives in its Nov '26 announcement.
- launchesNov 1, 2026
LipoTrue, SL introduces Glintarine, a marine ferment designed to regulate melanin dynamics during epidermal renewal and support brighter, smoother, more even-looking skin, at in-cosmetics Asia 2026.
- launchesNov 1, 2026
LipoTrue, SL introduces Kalizyme as one of three new biotechnological cosmetic actives at in-cosmetics Asia 2026.
For institutional investors. Book with your work email.
LipoTrue Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about LipoTrue's valuation, stock price, and market status.
Is LipoTrue a public or private company?
LipoTrue is a private company.
What is the current stock price of LipoTrue?
LipoTrue is a private company, so its shares have no public market price. Caplight tracks LipoTrue's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is LipoTrue worth (valuation)?
Valuation information for LipoTrue is not publicly available.
Can I buy LipoTrue stock?
LipoTrue shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was LipoTrue's last funding round?
LipoTrue's most recent funding round was Growth Equity on October 1, 2019.
Who are the main investors in LipoTrue?
Key investors in LipoTrue include Queka Real Partners.
Will LipoTrue IPO soon?
No public IPO plans have been announced for LipoTrue.
How can I track LipoTrue secondary market activity?
Caplight tracks bids, offers, and trades in LipoTrue's shares on secondary markets.